Immunization Coverage in Selected Communities in the Niger Delta, Nigeria


Background: The Expanded Program on Immunization was launched in Nigeria in 1980 but the target for immunization coverage has been elusive. As part of its social responsibilities the Shell Petroleum Development Company (SPDC) supported immunization activities in the Niger Delta region of the country. In this study a cross sectional study was carried out to estimate the coverage of BCG, OPV, DPT and measles vaccines and, to determine the predictors of full immunization coverage among children aged 12 to 23 months in selected SPDC supported communities in the Niger Delta. Using modified cluster randomization, 2432 children were included in the study. Results: Of 2432 children studied 1585 (65.2%; 95% CI: 61.9% to 68.5%) were fully immunized with the four vaccines; 2323 (95.5%) had received at least one dose of a vaccine (card and history). About one third (36.6%) of the children aged 12 to 23 months with immunization card were fully immunized by their first birthday. The proportion of children fully immunized with valid doses of vaccines by one year was 19.9% (485 of 2432) based on card only. One hundred and nine (4.5%) had never received immunization. Major reason for failure to be immunized was fear of side reactions. Main predictor for full immunization was availability of a health facility in the community. Discussion: The coverage of immunization was high in the study area; but the proportion of valid doses administered was low. Training of health workers and strategic behavioral communication to dispel fears of side reactions are recommended.

Share and Cite:

A. Oyo-Ita, B. Fakunle, A. Fajola and E. Edet, "Immunization Coverage in Selected Communities in the Niger Delta, Nigeria," World Journal of Vaccines, Vol. 2 No. 1, 2012, pp. 21-26. doi: 10.4236/wjv.2012.21003.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] F. E. Andre, R. Booy, H. L. Bock, J. Clemens, S. K. Datta, T. J. John, et al., “Vaccination Greatly Reduces Disease, Disability, Death and Inequity Worldwide,” Bulletin of the World Health Organization, Vol. 86, No. 2, 2008, pp 140-146. doi:10.2471/BLT.07.040089
[2] WHO, “Vaccine Preventable Deaths and the Global Immunization Vision and Strategy, 2006-2015,” World Health Organization, Geneva, 2006.
[3] WHO, “Tetanus Eradication in 12 Regions on the Globe,” 2010.
[4] WHO, “Smallpox Eradication History,” 2010.
[5] P Fine, “Herd Immunity: History, Theory, Practice,” Epidemiologic Reviews, Vol. 15, No. 2, 1993, pp. 265-302.
[6] National Population Commission (NPC) and ORC Macro, “Nigeria National Demographic Health Survey, 2003,” NPC and ORC Macro, Calverton, 2004.
[7] National Bureau of Statistics (NBS), “Nigeria Multiple Indicator Cluster Survey 2007 Final Report,” Abuja, 2007, p. 12.
[8] Shell Petroleum Development Company, “Shell in Nigeria; Improving Lives in the Niger Delta,” 2011.
[9] Family Health International, “End of Project Report: Niger Delta AIDS Response Project,” Abuja, 2009, p. 1.
[10] H. T. Ejibuno, “Nigeria’s Niger Delta Crisis: Root Causes of Peacelessness,” EPU Research Papers, Vol. 7. No. 7, 2011.
[11] National Population Commission (NPC) and ICF Macro, “National Demographic and Health Survey, 2008,” NPC and ICF Macro, Abuja, 2009, p. 15.
[12] WHO, “Immunization Coverage Cluster Survey Reference Manual,” World Health Organization, Geneva, 2005.
[13] E. M. Santiago, E. Lawson, K. Gillenwater, S. Kalangi, A. G. Lescano, G. Quella, K. Cummings, L Cabrera, C Torres and R. H. Gilman, “A Prospective Study of Bacillus Calmette-Guérin Scar Formation and Tuberculin Skin Test Reactivity in Infants in Lima,” Peru PEDIATRICS Vol. 112, No. 4, 2003.
[14] M. G. Betz and A. F. Grunfeld, “Fever Phobia’ in the Emergency Department: A Survey of Children’s Caregivers,” European Journal of Emergency Medicine, Vol. 13, No. 3, 2006, pp. 129-133. doi:10.1097/01.mej.0000194401.15335.c7

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.